Inspire Medical Systems (INSP) reported Q1 earnings Monday of $0.10 per diluted share, compared with a net loss of $0.34 per share a year earlier.
Analysts polled by FactSet expected a loss of $0.27 per share.
Revenue for the quarter ended March 31 was $201.3 million, up from $164.0 million a year earlier.
Analysts surveyed by FactSet expected $195.2 million.
The company said it's increasing its 2025 diluted EPS guidance to between $2.20 and $2.30, from the previous guidance between $2.10 and $2.20. The company maintained its 2025 revenue outlook of between $940 million and $955 million.
Analysts polled by FactSet expect $2.17 and $949.6 million.
The company's shares were rising past 2% in recent after-hours trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.